Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

A low-income housing cooperative for people with HIV and AIDS is fighting to stay open in San Francisco. On Sunday afternoon, ...

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

In an unprecedented crisis, a small town called Taunsa Sharif, located in South Punjab, is grappling with an alarming outbreak of HIV/AIDS among minor children aged from nine months to 10 years, with ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

Prevalence varies by region and is impacted by social stigma, access to preventive medicine and a lack of HIV/AIDS education, ...

Dayton & Montgomery County Public Health hosted its ninth annual “Rocking our Red Pumps” event on Friday to recognize ...